Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (17)	8/18/2000 4:36:50 AM
From: nigel bates	of 278

Don't know if you saw this. Can't imagine why a neuro company would want to merge with Xenova. Too much competition in the cancer arena IMO - LONDON, Aug 16 (Reuters) - Shares in British biotechnology company Xenova Plc closed over 16 percent up on Wednesday as speculation mounted it was in merger talks with another biotech firm, CeNes Pharmaceuticals (LSE: CEN.L - news) . Industry sources told Reuters that both companies, which have in past explored the possibility of coming together, have resumed talks but they were at a very early stage. A merger would combine Xenova's platform of cancer products with the central nervous system product base of CeNes. Neither Xenova nor CeNes was willing to comment on the talks but one source said the deal is likely to be formally announced after CeNes completes all formalities regarding its purchase of Cambridge Neuroscience Inc , a Nasdaq-listed company which it was buying for $44 million..."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next